TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CellSource Co., Ltd. ( (JP:4880) ) has shared an update.
CellSource Co., Ltd. has revised its financial forecast for the fiscal year ending October 31, 2025, due to lower-than-expected net sales and profit. The revision is attributed to changes in contract terms for medical institution support services and slower-than-anticipated results from measures to increase orders for contract processing services. The company expects flat sales in contract processing services for self-funded medical institutions and anticipates increased orders from hybrid-type institutions in the fourth quarter.
The most recent analyst rating on (JP:4880) stock is a Hold with a Yen742.00 price target. To see the full list of analyst forecasts on CellSource Co., Ltd. stock, see the JP:4880 Stock Forecast page.
More about CellSource Co., Ltd.
CellSource Co., Ltd. operates in the medical services industry, focusing on contract processing services and medical institution support services. The company is listed on the Tokyo Stock Exchange, Prime Market.
Average Trading Volume: 55,295
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen12.13B
Find detailed analytics on 4880 stock on TipRanks’ Stock Analysis page.